GlaxoSmithKline plc (GSKN) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.141x

Based on the latest financial reports, GlaxoSmithKline plc (GSKN) has a cash flow conversion efficiency ratio of 0.141x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (MX$2.22 Billion ≈ $127.88 Million USD) by net assets (MX$15.75 Billion ≈ $906.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of GlaxoSmithKline plc to measure how many days the company can operate on defensive assets alone.

GlaxoSmithKline plc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how GlaxoSmithKline plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GlaxoSmithKline plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GlaxoSmithKline plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sanofi MX:SNYN	0.023x
Marriott International Inc NASDAQ:MAR	-0.210x
Sanofi F:SNW2	0.051x
Medtronic plc SA:MDTC34	0.097x
AIR LIQUIDE ADR 1/5/EO 11 F:AILA	N/A
INTESA SANPAOLO ADR/6 F:IESJ	N/A
State Bank of India NSE:SBIN	-0.265x
Trane Technologies plc NYSE:TT	0.136x

Annual Cash Flow Conversion Efficiency for GlaxoSmithKline plc (2013–2024)

The table below shows the annual cash flow conversion efficiency of GlaxoSmithKline plc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see GSKN company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	MX$13.09 Billion ≈ $753.10 Million	MX$6.55 Billion ≈ $377.18 Million	0.501x	+17.00%
2023-12-31	MX$12.79 Billion ≈ $736.36 Million	MX$5.48 Billion ≈ $315.20 Million	0.428x	-41.62%
2022-12-31	MX$10.10 Billion ≈ $581.03 Million	MX$7.40 Billion ≈ $426.04 Million	0.733x	+96.80%
2021-12-31	MX$21.34 Billion ≈ $1.23 Billion	MX$7.95 Billion ≈ $457.64 Million	0.373x	-8.15%
2020-12-31	MX$20.81 Billion ≈ $1.20 Billion	MX$8.44 Billion ≈ $485.78 Million	0.406x	-7.15%
2019-12-31	MX$18.36 Billion ≈ $1.06 Billion	MX$8.02 Billion ≈ $461.55 Million	0.437x	-80.95%
2018-12-31	MX$3.67 Billion ≈ $211.32 Million	MX$8.42 Billion ≈ $484.63 Million	2.293x	+15.66%
2017-12-31	MX$3.49 Billion ≈ $200.79 Million	MX$6.92 Billion ≈ $398.13 Million	1.983x	+51.46%
2016-12-31	MX$4.96 Billion ≈ $285.62 Million	MX$6.50 Billion ≈ $373.90 Million	1.309x	+352.40%
2015-12-31	MX$8.88 Billion ≈ $510.93 Million	MX$2.57 Billion ≈ $147.85 Million	0.289x	-72.41%
2014-12-31	MX$4.94 Billion ≈ $284.07 Million	MX$5.18 Billion ≈ $297.88 Million	1.049x	+13.43%
2013-12-31	MX$7.81 Billion ≈ $449.58 Million	MX$7.22 Billion ≈ $415.63 Million	0.924x	--

About GlaxoSmithKline plc

MX:GSKN Mexico Drug Manufacturers - General

Market Cap

$104.06 Billion

MX$1.81 Trillion MXN

Market Cap Rank

#238 Global

#9 in Mexico

Share Price

MX$901.11

Change (1 day)

-0.98%

52-Week Range

MX$710.00 - MX$1041.90

All Time High

MX$1096.34